{"ticker": {"uuid": "e4d0d526-cf46-4a7e-a142-6ede41e69794", "symbol": "BNGO", "name": "Bionano Genomics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Instruments & Supplies"}, "articles": [{"title": "Precision Trading with Bionano Genomics Inc. (BNGO) Risk Zones", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxQYmloRDdrdURSclFUTEpHYjlTMjRhSEpVNmVscjVfMXFEX3VEMHBkWjExd0FyRndQZ2Rsa3ZINnpYb1R4VU9UOUVoVW1vR0VqUVhLLTJwWHhub1pfMGpqblQ4OERqT3V0al95eFp2a2lsRmk0bzV6djAtaGtrY3h5UVRyd3RVajRDeEdVM1k0M3VrREw1akEwV2R6bmVNSVRDczFQcUVTZjJBdHlISUtuVGFWTWJMYnpCYWUxSWQ3dHJoQ3FZWEJ6aTAwcFV4a0FmLTZWUlFaNA?oc=5", "source_name": "Stock Traders Daily", "published_at": "2026-07-15T05:46:01+00:00", "published_display": "15 Jul 2026 05:46", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nabsys selects first-ever chief medical officer", "summary": "Nabsys 2.0 LLC, an electronic genome-mapping company, has appointed Alka Chaubey as its first chief medical and genomics officer. Chaubey, formerly CMO of Bionano Genomics Inc., will lead Nabsys' medical and scientific affairs, industry collaborations, and expand electronic genom", "url": "https://pbn.com/nabsys-selects-first-ever-chief-medical-officer/?amp=1", "source_name": "Providence Business News", "published_at": "2026-07-13T02:11:39", "published_display": "13 Jul 2026 02:11", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nabsys Appoints Genome Mapping Pioneer Alka Chaubey, Ph.D., as Chief Medical and Genomics Officer", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/nabsys-appoints-genome-mapping-pioneer-120000719.html", "source_name": "PR Newswire", "published_at": "2026-07-06T12:00:00+00:00", "published_display": "06 Jul 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Bionano Genomics, Inc. \u2013 NASDAQ:BNGO", "summary": "This article provides financial information for Bionano Genomics, Inc. (NASDAQ: BNGO), specifically focusing on its price-to-sales forward metric. The content, sourced from TradingView, indicates \"No trades\" and \"Market closed,\" suggesting a financial snapshot rather than live ma", "url": "https://www.tradingview.com/symbols/NASDAQ-BNGO/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-03T11:09:17", "published_display": "03 Jul 2026 11:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of Bionano Genomics, Inc. \u2013 NASDAQ:BNGO", "summary": "This page provides financial information for Bionano Genomics, Inc. (NASDAQ: BNGO), specifically focusing on its forward price-to-book ratio. The content is primarily a data placeholder from TradingView, indicating that the value and changes for this metric are available for spec", "url": "https://www.tradingview.com/symbols/NASDAQ-BNGO/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-07-03T02:40:47", "published_display": "03 Jul 2026 02:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics, Inc. (BNGO) reports Q1 loss, tops revenue estimates", "summary": "Bionano Genomics, Inc. (BNGO) announced a narrower-than-expected loss for the first quarter, reporting a loss of 6 cents per share, which is 2 cents better than the Zacks Consensus Estimate. The company also surpassed revenue expectations, bringing in $8.95 million against an est", "url": "https://www.msn.com/en-us/money/other/bionano-genomics-inc-bngo-reports-q1-loss-tops-revenue-estimates/ar-AA238b8G?ocid=BingNewsVerp", "source_name": "MSN", "published_at": "2026-06-25T17:11:19", "published_display": "25 Jun 2026 17:11", "sentiment": "positive", "sentiment_pct": 61, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics, Inc. Actuals & Estimates (NASDAQ:BNGO)", "summary": "This article provides an overview of Bionano Genomics, Inc. (NASDAQ: BNGO) stock, including its current price, market capitalization, and analyst forecasts. It details financial metrics such as earnings per share and revenue, notes the company does not pay dividends, and offers i", "url": "https://www.tradingview.com/symbols/NASDAQ-BNGO/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-25T15:11:19", "published_display": "25 Jun 2026 15:11", "sentiment": "negative", "sentiment_pct": 40, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BNGO Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast for Bionano Genomics, Inc. (BNGO) stock, including analyst price targets, historical performance data, and financial metrics. Analysts project a maximum price of $6.00 and a minimum of $4.00 for BNGO. The company's stock has seen significant decli", "url": "https://www.tradingview.com/symbols/NASDAQ-BNGO/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-25T14:11:19", "published_display": "25 Jun 2026 14:11", "sentiment": "negative", "sentiment_pct": 35, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics Names Alex Hastie Chief Scientific Officer", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxNZlBLX0lHaGltMmtuQ21mRHpiMXlNSGxvcHlSemJjc1lsbDAydTU5MDNwU0dibGs5R0Vza1VjZno0d0xXSnp2TUxJcUpmbHIxSEZhTmY5N0RYRkdRbEQwRHcwSlFVLS1VeHVGcFdSbFdPb1Rlc21SZ2FHVnRPOUxDcktWMTlIRHZoelBtNHkyVU5ob2dQSmR6UXhLUUZYMkFpb0t6SHozbWhQTkYwWEEyNWVkalpkY2Vsbm1iNjNIQVI2OVNuNk1LekxQR09ERjhDcm1aR0F4UkFhdzdm?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BNGO: Reproductive And Prenatal Genomic Advances Will Drive Future Upside", "summary": "Bionano Genomics (BNGO) is seeing its fair value trimmed to $5.00 from $5.50 by analysts, despite advancements in reproductive and prenatal genetics using optical genome mapping (OGM). Recent studies highlight OGM's effectiveness in identifying genetic causes of infertility and i", "url": "https://simplywall.st/community/narratives/us/pharmaceuticals-biotech/nasdaq-bngo/bionano-genomics/fepqhetx-digital-pathology-transition-will-advance-precision-medicine-adoption-gnae/updates/11-analysts-have-trimmed-their-bionano-genomics-price-target-to", "source_name": "Simply Wall Street", "published_at": "2026-06-24T20:10:24", "published_display": "24 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics appoints Alex Hastie as chief scientific officer By Investing.com", "summary": "Bionano Genomics has appointed Alex Hastie, Ph.D., as its new Chief Scientific Officer, effective July 20. Dr. Hastie, who previously spent 14 years at Bionano contributing to its optical genome mapping technology, will now lead the company's scientific strategy, innovation, and ", "url": "https://za.investing.com/news/stock-market-news/bionano-genomics-appoints-alex-hastie-as-chief-scientific-officer-93CH-4341983", "source_name": "Investing.com South Africa", "published_at": "2026-06-24T19:09:47", "published_display": "24 Jun 2026 19:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Announces Hiring of Chief Scientific Officer", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/bionano-announces-hiring-chief-scientific-123000298.html", "source_name": "GlobeNewswire", "published_at": "2026-06-24T12:30:00+00:00", "published_display": "24 Jun 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano brings back OGM pioneer to lead science strategy July 20", "summary": "Bionano (NASDAQ: BNGO) has appointed Alex Hastie, Ph.D., as its Chief Scientific Officer, effective July 20, 2026. Dr. Hastie, a pivotal figure in Bionano's optical genome mapping (OGM) technology for 14 years, will now lead the company's global scientific strategy, innovation, a", "url": "https://www.stocktitan.net/news/BNGO/bionano-announces-hiring-of-chief-scientific-wpf8tya9iw5l.html", "source_name": "Stock Titan", "published_at": "2026-06-24T12:40:07", "published_display": "24 Jun 2026 12:40", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano appoints Alex Hastie as Chief Scientific Officer to lead global science strategy", "summary": "Bionano has appointed Alex Hastie, Ph.D. as Chief Scientific Officer, effective July 20, 2026. Hastie, who previously helped develop Bionano's optical genome mapping technology, will now lead the company's global scientific strategy, focusing on expanding clinical research applic", "url": "https://www.tradingview.com/news/tradingview:925f326ba94c6:0-bionano-appoints-alex-hastie-as-chief-scientific-officer-to-lead-global-science-strategy/", "source_name": "TradingView", "published_at": "2026-06-24T12:40:07", "published_display": "24 Jun 2026 12:40", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alex Hastie returns as Chief Scientific Officer at Bionano Genomics (NASDAQ: BNGO)", "summary": "Bionano Genomics, Inc. (NASDAQ: BNGO) announced the appointment of Alex Hastie, Ph.D., as its Chief Scientific Officer, effective July 20, 2026. Hastie, who previously spent 14 years at Bionano and was instrumental in developing its optical genome mapping (OGM) technologies, will", "url": "https://www.stocktitan.net/sec-filings/BNGO/8-k-bionano-genomics-inc-reports-material-event-1ed8c4e5b6ab.html", "source_name": "Stock Titan", "published_at": "2026-06-24T12:40:06", "published_display": "24 Jun 2026 12:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics (BNGO) Slips 1.72% as Stock Tests Key Support Levels - Factor Momentum", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxPSjB2XzJ0ejZjMFBUTEZHa3BMZzZ5VTk0N2pfamh1SkR6eTRYblp6U1hUTVAyaW9sVFRxc3V4bnJwelpiZ0h1bU9NeW5Ob3VmUGhPemJwWlhVNGo5QWhXRVNSem9Vemw3OHFEeC1nT1FRbkNZM2JMdi1aOWFXNG40ZVlnSnowbGtyQUw5bGVkQjlPdUN0X1dyY2R6TkJVMXpEaVRaOXh4SzFzak9oeHBFeXk0OHk?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-06-21T07:00:00+00:00", "published_display": "21 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Announces 67% Year-Over-Year Growth in Studies Featuring Optical Genome Mapping at ESHG 2026, Reflecting Expanding Global Adoption", "summary": "Bionano Genomics reported a 67% year-over-year increase in studies featuring optical genome mapping (OGM) at the 2026 European Society of Human Genetics (ESHG) conference, indicating growing global adoption. The 35 studies, up from 21 in 2025, originated from 17 countries across ", "url": "https://www.manilatimes.net/2026/06/18/tmt-newswire/globenewswire/bionano-announces-67-year-over-year-growth-in-studies-featuring-optical-genome-mapping-at-eshg-2026-reflecting-expanding-global-adoption/2368363/amp", "source_name": "The Manila Times", "published_at": "2026-06-18T20:16:00", "published_display": "18 Jun 2026 20:16", "sentiment": "positive", "sentiment_pct": 95, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano\u2019s genome-mapping studies jump to 35 at ESHG 2026", "summary": "Bionano (Nasdaq: BNGO) announced a 67% year-over-year increase in studies featuring its optical genome mapping (OGM) technology at ESHG 2026, reaching 35 studies from 17 countries. This growth highlights expanding global adoption across various research areas like rare genetic di", "url": "https://www.stocktitan.net/news/BNGO/bionano-announces-67-year-over-year-growth-in-studies-featuring-4tp1hdvm99bk.html", "source_name": "Stock Titan", "published_at": "2026-06-18T12:11:33", "published_display": "18 Jun 2026 12:11", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics Inc (BNGO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a detailed revenue breakdown for Bionano Genomics Inc (BNGO),", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bngo/revenue", "source_name": "TradingKey", "published_at": "2026-06-18T09:11:33", "published_display": "18 Jun 2026 09:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics reports 67% increase in studies at genetics conference", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxOUERuQ3RhRTNaM0owWGsxeW9wMEUzQ0p1dWRCUXNHN1I0dE1UTmZ3Y1BnbERrUGZ1ZDRBWGpkQnExNDVBRWF5amZmaDF0d0g1NTlKNHNmaURRYU5ZenotcHliTHdoTXN4QWRqQnF4b1Q3YTFybHlnRWRfd3dlZHRDSkY3Vl8zYzZYdDhIXzJMdVlXRTZvOEZpNXVJc2J2cjMtaUZDZXJUdHRGNjhpbG5wXzhTLTAtN1NuVThHQ0EzV1prT0pBbWc?oc=5", "source_name": "Investing.com", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics Inc (BNGO) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides details on the dividend and stock split history of Bionano Genomics Inc (BNGO). It notes that the company has not distributed any dividends in the past five years. However, it lists several stock merger events, including a 60-to-1 merger scheduled for Januar", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bngo/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-18T00:40:29", "published_display": "18 Jun 2026 00:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics Inc (BNGO) Risk Assessment: Volatility, Financial Risk & Investment Risk", "summary": "", "url": "https://news.google.com/rss/articles/CBMid0FVX3lxTE9kbUZELTBxUWw0V2gwRTdTOXhzSFFYQ1cxSlh2eWZlbEVCdjdNWHQwZkFSVi1ndEZsWDV6NEdrdWZCVURsbTdFTWFQa2hrcU1hQko5LTNVZElEdlJqem1VX1M0S1dzTlI5R0tmaGEtN0ZtRXlxWHJN?oc=5", "source_name": "TradingKey", "published_at": "2026-06-17T22:47:40+00:00", "published_display": "17 Jun 2026 22:47", "sentiment": "negative", "sentiment_pct": 5, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics Inc (BNGO) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "", "url": "https://news.google.com/rss/articles/CBMicEFVX3lxTE1FbDB5b0lqRkdSNC1TTE83WmlLMVh2NDR6YmRRRlNVRnctQThDS2pydmVMUkRxZ29BSnVHcXA2cUVDT1RuU1NGMzd4aS16SXFXZnNjdTY0cXFqRHFBdmc1dndkWWZIektjcV9oVmg0bDk?oc=5", "source_name": "TradingKey", "published_at": "2026-06-17T21:49:02+00:00", "published_display": "17 Jun 2026 21:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics Inc (BNGO) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "The article details the shareholder structure of Bionano Genomics Inc (BNGO), listing its major shareholders and institutional holdings. Key shareholders include Lincoln Alternative Strategies LLC and GSA Capital Partners LLP, with breakdowns by shareholder type such as hedge fun", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bngo/ownership", "source_name": "TradingKey", "published_at": "2026-06-17T22:40:29", "published_display": "17 Jun 2026 22:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics Inc (BNGO) Institutional Confidence", "summary": "Bionano Genomics Inc (BNGO) has an institutional shareholding score of 3.00, placing it 132nd out of 204 in the Healthcare Equipment & Supplies industry. The institutional shareholding proportion has increased by 354.71% quarter-over-quarter, reaching 10.52%. James Simons is the ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bngo/sentiment", "source_name": "TradingKey", "published_at": "2026-06-17T22:11:33", "published_display": "17 Jun 2026 22:11", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics Inc (BNGO) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "Bionano Genomics Inc (BNGO) has an earnings forecast score of 8.00 and an average price target of $7.50, with a high of $8.00 and a low of $7.00. Based on two analysts, the stock has a \"Buy\" rating with a target price upside of +334.78%. The company's expected revenue for the nex", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bngo/earnings", "source_name": "TradingKey", "published_at": "2026-06-17T18:40:29", "published_display": "17 Jun 2026 18:40", "sentiment": "positive", "sentiment_pct": 67, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Announces Multiple Publications in 2026 Describing Unique Utility of OGM in Studies of Reproductive Health and Prenatal Genetic Disorders", "summary": "Bionano Genomics announced 13 studies published in 2026, analyzing 730 samples, demonstrate the utility of optical genome mapping (OGM) for detecting structural variants in reproductive health and prenatal genetic disorders. These studies, conducted by independent research groups", "url": "https://www.manilatimes.net/2026/06/11/tmt-newswire/globenewswire/bionano-announces-multiple-publications-in-2026-describing-unique-utility-of-ogm-in-studies-of-reproductive-health-and-prenatal-genetic-disorders/2363593/amp", "source_name": "The Manila Times", "published_at": "2026-06-11T12:10:15", "published_display": "11 Jun 2026 12:10", "sentiment": "positive", "sentiment_pct": 93, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Infertility gene clues: 13 studies find hidden variants with Bionano mapping", "summary": "Bionano announced that 13 independent studies published in 2026 utilized optical genome mapping (OGM) to analyze 730 samples in reproductive health and prenatal genetics. These studies demonstrated OGM's effectiveness in identifying structural variants often missed by standard me", "url": "https://www.stocktitan.net/news/BNGO/bionano-announces-multiple-publications-in-2026-describing-unique-jxvucer5k4k1.html", "source_name": "Stock Titan", "published_at": "2026-06-11T12:10:15", "published_display": "11 Jun 2026 12:10", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans - moomoo", "summary": "This article details Bionano Genomics' S-8 filing, which is an initial registration statement concerning securities offered to employees through employee benefit plans. The filing was submitted to the SEC.", "url": "https://www.moomoo.com/news/notice/306737748/bionano-genomics-s-8-initial-registration-statement-for-securities-to", "source_name": "Moomoo", "published_at": "2026-06-09T07:39:07", "published_display": "09 Jun 2026 07:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics (BNGO) Upgraded to Buy: What Does It Mean for the Stock?", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxQbFl4VzE3WkVUY1ZzUnZFV0ZrdnlDVUdoaXZLZEhOb2V6UVdSVjVwRDZYYTRmdUJKb1Y0SW9OaW16dm13ZThteGJaWjJpUEJSMkZSSnBhRTgyOGstdHlwbFhvYUl2eDRQYWhJV2lBUW4xQ0ZxaU9xZl9Sa3JEU2d0dGY4a3JObnhGV0pQX3dkTWcxelFVa19YdWV6OFdZMlU4?oc=5", "source_name": "Market source", "published_at": "2026-06-08T07:00:00+00:00", "published_display": "08 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNano Genomics Announces Resignation of Chief Medical Officer", "summary": "BioNano Genomics announced the resignation of its Chief Medical Officer, Alka Chaubey, Ph.D., effective July 5, 2026. This departure may lead to adjustments in the company's clinical strategy. Analysts currently rate BNGO stock as a Buy with a $4.00 price target, though Spark, Ti", "url": "https://www.theglobeandmail.com/investing/markets/stocks/BNGO/pressreleases/2343224/bionano-genomics-announces-resignation-of-chief-medical-officer/", "source_name": "The Globe and Mail", "published_at": "2026-06-07T13:09:41", "published_display": "07 Jun 2026 13:09", "sentiment": "negative", "sentiment_pct": 38, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics (NASDAQ: BNGO) Chief Medical Officer to step down", "summary": "Bionano Genomics, Inc. announced that its Chief Medical Officer, Alka Chaubey, Ph.D., submitted her resignation on June 2, 2026, which will become effective on July 5, 2026. The company, traded on Nasdaq under BNGO, reported this material event in an 8-K filing. Albert A. Luderer", "url": "https://www.stocktitan.net/sec-filings/BNGO/8-k-bionano-genomics-inc-reports-material-event-d0d2275f7087.html", "source_name": "Stock Titan", "published_at": "2026-06-05T19:41:04", "published_display": "05 Jun 2026 19:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano appoints board chairman as interim CEO", "summary": "Bionano Genomics, Inc. (NASDAQ:BNGO) has appointed Al Luderer, its current board chairman, as interim president and CEO, effective Monday. Luderer, who has extensive biotechnology experience, will continue as chairman while Chris Twomey becomes Lead Independent Director. This lea", "url": "https://www.investing.com/news/company-news/bionano-appoints-board-chairman-as-interim-ceo-93CH-4665440", "source_name": "Investing.com", "published_at": "2026-06-05T11:09:15", "published_display": "05 Jun 2026 11:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics (BNGO) counsel has 24 shares withheld for RSU taxes", "summary": "Bionano Genomics' General Counsel, Jonathan V. Dixon, recently had 24 common shares withheld by the company to cover tax obligations related to a vested Restricted Stock Unit (RSU) award. This routine tax-withholding disposition, occurring on June 3, 2026, was priced at $1.30 per", "url": "https://www.stocktitan.net/sec-filings/BNGO/form-4-bionano-genomics-inc-insider-trading-activity-4d3b2e816d04.html", "source_name": "Stock Titan", "published_at": "2026-06-04T10:39:24", "published_display": "04 Jun 2026 10:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics (BNGO) COO records 27-share tax withholding event", "summary": "Bionano Genomics Chief Operating Officer Mark Oldakowski reported a tax-related disposition of 27 shares of common stock. These shares, valued at $1.30 each, were withheld by the company on June 3, 2026, to cover tax obligations arising from a vested restricted stock unit (RSU) a", "url": "https://www.stocktitan.net/sec-filings/BNGO/form-4-bionano-genomics-inc-insider-trading-activity-73e23c002fb6.html", "source_name": "Stock Titan", "published_at": "2026-06-04T01:10:06", "published_display": "04 Jun 2026 01:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics (BNGO) CMO has 24 vested shares withheld for tax obligations", "summary": "Bionano Genomics' Chief Medical Officer, Alka Chaubey, had 24 shares of common stock withheld by the company to cover tax obligations on vested restricted stock units (RSUs). The shares, valued at $1.30 each, were part of an RSU award granted on June 3, 2024, which vested on June", "url": "https://www.stocktitan.net/sec-filings/BNGO/form-4-bionano-genomics-inc-insider-trading-activity-5dbb823b71d7.html", "source_name": "Stock Titan", "published_at": "2026-06-04T01:10:06", "published_display": "04 Jun 2026 01:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics (BNGO) officer reports 7-share tax withholding", "summary": "Bionano Genomics' Principal Accounting Officer, Mark Adamchak, reported a routine tax-related share withholding of 7 common stock shares on June 3, 2026. The shares, valued at $1.30 each, were withheld by the company to cover tax obligations when an RSU award vested. Following th", "url": "https://www.stocktitan.net/sec-filings/BNGO/form-4-bionano-genomics-inc-insider-trading-activity-086054f5b100.html", "source_name": "Stock Titan", "published_at": "2026-06-04T01:10:06", "published_display": "04 Jun 2026 01:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Announces Full Retirement of Outstanding Senior Secured Convertible Debentures", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/bionano-announces-full-retirement-outstanding-120000380.html", "source_name": "GlobeNewswire", "published_at": "2026-05-28T12:00:00+00:00", "published_display": "28 May 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Fast-paced Mover Bionano Genomics (BNGO) Is a Great Choice for Value Investors", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPVUI5Y2pzeWMyRUpEOUFTWGFnYXQ0NnVBZG40bGs5SlJpelZ2TkR2U0Y5MzNsdkJHekRKMWhPbGpONVVjUkZUc1drZGpnZE12Slo0RTFSZWp6bnJobE1XZFhmVW9Za2xkaUpoemV1RGdBYUUyUkp3NDRmS1RCc2dhOUZ1WEpvU0xQR1NTZDBxUGZhUm94LUptUQ?oc=5", "source_name": "Market source", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Announces Largest OGM Study of T-Cell Acute Lymphoblastic Leukemia", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/bionano-announces-largest-ogm-study-120000855.html", "source_name": "GlobeNewswire", "published_at": "2026-05-26T12:00:00+00:00", "published_display": "26 May 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings call transcript: Bionano Genomics sees Q1 revenue growth, stock edges up", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxPd2RGWjJWUnhrX3lfMjF0cEdDSjhzNXVvbi1uR2RmMzVpY0t4RUdHbWFDYVF1SFQ5WVBPdHhtMzFBYkh4MlA4dk5zYzFwZGlrSFJKOTg5NWc5N3g3NllWc3AzVC1ZNG5xaVdIX2JaTVdCNFRmbnlSd193aHNHeXJCRXluaXBPb0hjUDZlOEpITGpYdFVlalJhd2tnd29RT1drX2FNYzVwRkJLLWdnNm1jQmRXQnI4MEppQll1WWJMejdZZTdyaTFENEVMb25nd0Zq?oc=5", "source_name": "Investing.com", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics, Inc. Q1 2026 Earnings Call Summary", "summary": "", "url": "https://finance.yahoo.com/m/e44ec90b-77b8-3bf3-a414-66e8e831afec/bionano-genomics%2C-inc.-q1.html", "source_name": "Moby", "published_at": "2026-05-14T12:30:00+00:00", "published_display": "14 May 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNano Genomics Names Interim CEO Amid Leadership Transition", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxPT0pwUGpJX1NTUzllNXpTOWUxVjU4TXdDcWlQNGpRV2c1LWF6blBhZ3lucEdsNF9yZlZVVlI1bFhTeTNNc1luN2hidW5nUVk5ZmxrQzRIMTF5S2VzeE9rZmQ4Qm1Kb1JqTU9KZ0xWeVVocHp5YmlOcnA2eUhOa1NzaThfZkN0MEw1bVdfRkY3R095UzUtam9sV215Y0VTMTBDcldXSFRsSE9STW5UOWVHZVFZTDNjVzBLd0Q0MW0xNHZPTjN2Y3NyQ2hBQTJZbnB5U01uZkRHUGw3MEpUVTJN?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics, Inc. Q4 2025 Earnings Call Summary", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNd19iWjBRZnZYMjNWbWJkV0VocXUxUjI2cVNMak16X3JmQTVNa1JKRk10TFFIMEI2N1pRZTd6UTk1NjZJek1YdUEzSTQzejRzMDVXUGgtdVpaQjRDMjFlMG5MZmxrY0VWWlZ0c3lkR0pKS3h0WjJVRXhWSTI4SFk0XzFlZG1wZ2tnOWpBMzRsbk5tVFBNTS1Eb21YSko2dw?oc=5", "source_name": "Market source", "published_at": "2026-03-23T07:00:00+00:00", "published_display": "23 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Market Cool On Bionano Genomics, Inc.'s (NASDAQ:BNGO) Revenues", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-30T08:00:00+00:00", "published_display": "30 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics Second Quarter 2025 Earnings: Beats Expectations", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-08-16T07:00:00+00:00", "published_display": "16 Aug 2025 07:00", "sentiment": "positive", "sentiment_pct": 85, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano to Report Second Quarter 2025 Financial Results and Host", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgJBVV95cUxPU3VfSmkxSDQyNzFtNDN4X2REYWpwWnlxdUFMTnhVMkpXUXBvZVV1SUNhR2JMTkhkU0swNTVLY19pTEt0MHNVaFF1dmJlQ0lmUlpRaG9ZemJQSERSa1pkdm5zLW9tbzZaX2djelpBZkhHaUN5T2FmS3RtUlJROWRoNERCUTJfSVZmWTd3YkN4bTZvUm5MRTdDYk1CVGw0TmF4M2ZHOWNBeEptNnpvNE1YRDZ4bnZrbHlNc3lfckxoNm5vVU1wZXJ6ME9XZ3IxX3JTcjBuVkdUemZKd1hvMkZmMEQzWUVudmFQNUVuT0ZPRWRWMnFrU0dORE1Ualk2Y1NRbnZzbWJn?oc=5", "source_name": "GuruFocus", "published_at": "2025-08-14T07:00:00+00:00", "published_display": "14 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics Retail Mood Turns \u2018Extremely Bearish\u2019 Amid Revenue Guidance Shortfall", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxPV29xcHlxaVBleEVnbFA4U19GSFNtcWtZcmZ2NkU2dG5ZZEx6cDIxUi1INjZzMVphOGpiLTRab1dmSURWV00xQkdkTXJqaS1XUzlpRG5zRlQ0bWNXSnE4QjRuTmh6Yl85Q1R2V2hJQ0VUWWN0RUU5OWljQl9CRDF2Sko0SlF0d1BVUnlhX3QtWEh0aXFPVmlnME9lZ0ZqQmpGNmJybEdsY09yU2dE?oc=5", "source_name": "Stocktwits", "published_at": "2025-05-15T03:12:29+00:00", "published_display": "15 May 2025 03:12", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics (BNGO) Stock Forecast and Price Target 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTFBDVTlVMTYwcTNPWU9sdVhLaWpibVExUlNOdjNpUC1VTlV4anZBNThYUko5Unk0bkxqSEVWQmJaUVlNMUhUdkxPaERObWxCMUR4VVN0SDNla2R2TU9LN0hIaDczdWRsdw?oc=5", "source_name": "MarketBeat", "published_at": "2024-05-11T13:08:05+00:00", "published_display": "11 May 2024 13:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What Is Going on With Bionano Genomics (BNGO) Stock Today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxQcVZELWtBeVl0eWxiejJwLVZDb0pmdEZFVmIySmZTZWpFZ0oybHBFYk9fdWd4Z3lsNnhndVp2eElZbmhxOV9YTUlxZWcwMnNuRmJaQXVKSldmWXRIWWpHd1pDcjNUSXdDVk16ZzZ5NXpDWDFkWTdjNWFrYVRGNlhCeURCSVZkVU5oRDZ2Tm1NVDkzMEY1?oc=5", "source_name": "InvestorPlace", "published_at": "2022-10-26T07:00:00+00:00", "published_display": "26 Oct 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics Stock: What Exactly Do They Do?", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTE1yVllMZk9MdkgzY2cyclVsMEVGM0ZFZHZyWjBNcFp0a1E1bEhGdTJzMXpqUTFndkRlQXJLNEZ4dHZKT3JxUTkxMEZMaTN6bHFFWkpkVHhTQzh6ZnYyYmxFQjBPS0xxdGpqZ05PdWczNDNXVDQxdUJjUQ?oc=5", "source_name": "Nanalyze", "published_at": "2022-04-13T07:00:00+00:00", "published_display": "13 Apr 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Is Not the Genomics Stock To Bet On", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxNME1LQ1UtTTZZczdvaGd6c3l5V2ZsVlNnY2tOZWYxZWNxVG1aOGNjTjdEVWozNUlYaDlhWS1YdDZjTXBLaEpLSWV5UDdEZmQtSi0wLTl2VHVhUGFQMWtxd0FZY0plRzBLcTVGVTI3M3JGSE96enRYSmhmWDEzb29iVUJ3?oc=5", "source_name": "Market source", "published_at": "2022-02-04T08:00:00+00:00", "published_display": "04 Feb 2022 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics Announces Closing of $230 Million", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2AJBVV95cUxPMlE5cnNkSjlDMkdsd0VjWE5pRXBiSDZVNFZKMzJOTXJDNXBGU2hwRGlwQU5Ybk5wMkpYSEdJMDI2azBHZ1NMV0hfaWx3ck94Sm04VDhwdHZoSURpRUoyWDlHOEI2WjNSc3d4anRhT0VJbndjdk45YWo0VjRwNWxPM2dDV0hwT1MtaWFWOVAtYVZSMC1nOGdCdlk4ekE2NmNSdmg0ZDVkWjNFdDk0cjJqc1g0dWUycHJxTUVoc3I1dElfVWliU1hoNXJqblpZMnUxRzdFOUppTC1jQ1lsbkRic0JFRzlodjc1Rk9kVldRU1VjU0pqUlVpNW1HV1h2TzJuejRTU1VlZkZSRGN3WVlVTHZZbXhBWktlMG56LU5VWFBPd1d4cl8wV0FKR1pQYTM2Uktuc19sTVFjX1FxMUc0b2lJcUpfWFVvdFpMVWplSFJnRlJaam5wUg?oc=5", "source_name": "GlobeNewswire", "published_at": "2021-01-25T08:00:00+00:00", "published_display": "25 Jan 2021 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics, Inc.: Target Price Consensus and Analysts Recommendations | BNGO | US09075F4046", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxPNl9QdDNfZlpYN29kVWxzUEZJUmRYekw0dlgxY0w5aFhjeDhGXzBuUFJCN3ptSUZUYXRoQ2JXMjlkV3ItVDBMUzVPOUNMcGhZNlJQTTBYYm5xUTdQVGpfUTdUWXpXMk5rb29NYkhlbklEVUtxOUtpZFB4Snl2NkozNjl0WnBVSlYzZW9R?oc=5", "source_name": "marketscreener.com", "published_at": "2020-08-31T22:03:04+00:00", "published_display": "31 Aug 2020 22:03", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics (BNGO) Stock News & Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTkFVX3lxTFBpVGxJREtuLXBYMEU2Mmd4Q1k4WEZZOGVFNDkxNGNPYWNnandmTGdvaWxrT1M5aEgwMV9nU2gwTE9nb0tMSnc4NVZiWDlHdw?oc=5", "source_name": "Stock Titan", "published_at": "2020-08-20T13:40:34+00:00", "published_display": "20 Aug 2020 13:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BNGO: Bionano Genomics - Full Company Report", "summary": "", "url": "https://news.google.com/rss/articles/CBMiaEFVX3lxTE9FT1RScGc5WjhBOTZZUF9wYm53aW5vMHFJYTNmbzRES3dmV0I0ZkJOOHdNZUNkY0EtbExqb1o1YTFjWFhCbjE5b2VMU2pNLUkxSWt3ZUFVZHlRdHhRVXBaVkQxZDJhc05r?oc=5", "source_name": "Zacks Investment Research", "published_at": "2018-09-26T10:50:58+00:00", "published_display": "26 Sep 2018 10:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics (BNGO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiT0FVX3lxTE9wSTlrV2JsVUhYRTJFd1N4YmxvNTAzV2U2REtpUTltMDZQYkN1dWJJZXltZ3JtdEYzVUJVLTFNRnRCU2tJWE16dHJmbXdHbjA?oc=5", "source_name": "Zacks Investment Research", "published_at": "2018-09-26T10:05:51+00:00", "published_display": "26 Sep 2018 10:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The maize W22 genome provides a foundation for functional genomics and transposon biology", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXkFVX3lxTE53LWNwX2psc3VpZjZFZHBCT2ZpNllhSjd6Njk2RWhuU1dkbjZwOExnc1FtZE5lcUptX3BxLVA1RndNQTkwVFJHM0VfbG1kc3BORDBCVkFIVnVWNjNkNHc?oc=5", "source_name": "Nature", "published_at": "2018-07-30T07:00:00+00:00", "published_display": "30 Jul 2018 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BNGO: Bionano Genomics Inc Latest Stock Price, Analysis, News and Trading Ideas", "summary": "", "url": "https://news.google.com/rss/articles/CBMiSkFVX3lxTE1adTQ4QzVJZnJVOFd2VWFRd0dGQnBSX2RIODI1QnltRlY5NS1xY1pDR0k2cU9iNUM5OGtCWjloTGEyX2pDUWQ0WjJn?oc=5", "source_name": "Stocktwits", "published_at": "2018-07-03T21:51:16+00:00", "published_display": "03 Jul 2018 21:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Precision Trading with Bionano Genomics Inc. (BNGO) Risk Zones", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxQYmloRDdrdURSclFUTEpHYjlTMjRhSEpVNmVscjVfMXFEX3VEMHBkWjExd0FyRndQZ2Rsa3ZINnpYb1R4VU9UOUVoVW1vR0VqUVhLLTJwWHhub1pfMGpqblQ4OERqT3V0al95eFp2a2lsRmk0bzV6djAtaGtrY3h5UVRyd3RVajRDeEdVM1k0M3VrREw1akEwV2R6bmVNSVRDczFQcUVTZjJBdHlISUtuVGFWTWJMYnpCYWUxSWQ3dHJoQ3FZWEJ6aTAwcFV4a0FmLTZWUlFaNA?oc=5", "source_name": "Stock Traders Daily", "published_at": "2026-07-15T05:46:01+00:00", "published_display": "15 Jul 2026 05:46", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nabsys selects first-ever chief medical officer", "summary": "Nabsys 2.0 LLC, an electronic genome-mapping company, has appointed Alka Chaubey as its first chief medical and genomics officer. Chaubey, formerly CMO of Bionano Genomics Inc., will lead Nabsys' medical and scientific affairs, industry collaborations, and expand electronic genom", "url": "https://pbn.com/nabsys-selects-first-ever-chief-medical-officer/?amp=1", "source_name": "Providence Business News", "published_at": "2026-07-13T02:11:39", "published_display": "13 Jul 2026 02:11", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nabsys Appoints Genome Mapping Pioneer Alka Chaubey, Ph.D., as Chief Medical and Genomics Officer", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/nabsys-appoints-genome-mapping-pioneer-120000719.html", "source_name": "PR Newswire", "published_at": "2026-07-06T12:00:00+00:00", "published_display": "06 Jul 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Bionano Genomics, Inc. \u2013 NASDAQ:BNGO", "summary": "This article provides financial information for Bionano Genomics, Inc. (NASDAQ: BNGO), specifically focusing on its price-to-sales forward metric. The content, sourced from TradingView, indicates \"No trades\" and \"Market closed,\" suggesting a financial snapshot rather than live ma", "url": "https://www.tradingview.com/symbols/NASDAQ-BNGO/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-03T11:09:17", "published_display": "03 Jul 2026 11:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of Bionano Genomics, Inc. \u2013 NASDAQ:BNGO", "summary": "This page provides financial information for Bionano Genomics, Inc. (NASDAQ: BNGO), specifically focusing on its forward price-to-book ratio. The content is primarily a data placeholder from TradingView, indicating that the value and changes for this metric are available for spec", "url": "https://www.tradingview.com/symbols/NASDAQ-BNGO/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-07-03T02:40:47", "published_display": "03 Jul 2026 02:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics, Inc. (BNGO) reports Q1 loss, tops revenue estimates", "summary": "Bionano Genomics, Inc. (BNGO) announced a narrower-than-expected loss for the first quarter, reporting a loss of 6 cents per share, which is 2 cents better than the Zacks Consensus Estimate. The company also surpassed revenue expectations, bringing in $8.95 million against an est", "url": "https://www.msn.com/en-us/money/other/bionano-genomics-inc-bngo-reports-q1-loss-tops-revenue-estimates/ar-AA238b8G?ocid=BingNewsVerp", "source_name": "MSN", "published_at": "2026-06-25T17:11:19", "published_display": "25 Jun 2026 17:11", "sentiment": "positive", "sentiment_pct": 61, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics, Inc. Actuals & Estimates (NASDAQ:BNGO)", "summary": "This article provides an overview of Bionano Genomics, Inc. (NASDAQ: BNGO) stock, including its current price, market capitalization, and analyst forecasts. It details financial metrics such as earnings per share and revenue, notes the company does not pay dividends, and offers i", "url": "https://www.tradingview.com/symbols/NASDAQ-BNGO/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-25T15:11:19", "published_display": "25 Jun 2026 15:11", "sentiment": "negative", "sentiment_pct": 40, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BNGO Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast for Bionano Genomics, Inc. (BNGO) stock, including analyst price targets, historical performance data, and financial metrics. Analysts project a maximum price of $6.00 and a minimum of $4.00 for BNGO. The company's stock has seen significant decli", "url": "https://www.tradingview.com/symbols/NASDAQ-BNGO/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-25T14:11:19", "published_display": "25 Jun 2026 14:11", "sentiment": "negative", "sentiment_pct": 35, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics Names Alex Hastie Chief Scientific Officer", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxNZlBLX0lHaGltMmtuQ21mRHpiMXlNSGxvcHlSemJjc1lsbDAydTU5MDNwU0dibGs5R0Vza1VjZno0d0xXSnp2TUxJcUpmbHIxSEZhTmY5N0RYRkdRbEQwRHcwSlFVLS1VeHVGcFdSbFdPb1Rlc21SZ2FHVnRPOUxDcktWMTlIRHZoelBtNHkyVU5ob2dQSmR6UXhLUUZYMkFpb0t6SHozbWhQTkYwWEEyNWVkalpkY2Vsbm1iNjNIQVI2OVNuNk1LekxQR09ERjhDcm1aR0F4UkFhdzdm?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BNGO: Reproductive And Prenatal Genomic Advances Will Drive Future Upside", "summary": "Bionano Genomics (BNGO) is seeing its fair value trimmed to $5.00 from $5.50 by analysts, despite advancements in reproductive and prenatal genetics using optical genome mapping (OGM). Recent studies highlight OGM's effectiveness in identifying genetic causes of infertility and i", "url": "https://simplywall.st/community/narratives/us/pharmaceuticals-biotech/nasdaq-bngo/bionano-genomics/fepqhetx-digital-pathology-transition-will-advance-precision-medicine-adoption-gnae/updates/11-analysts-have-trimmed-their-bionano-genomics-price-target-to", "source_name": "Simply Wall Street", "published_at": "2026-06-24T20:10:24", "published_display": "24 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics appoints Alex Hastie as chief scientific officer By Investing.com", "summary": "Bionano Genomics has appointed Alex Hastie, Ph.D., as its new Chief Scientific Officer, effective July 20. Dr. Hastie, who previously spent 14 years at Bionano contributing to its optical genome mapping technology, will now lead the company's scientific strategy, innovation, and ", "url": "https://za.investing.com/news/stock-market-news/bionano-genomics-appoints-alex-hastie-as-chief-scientific-officer-93CH-4341983", "source_name": "Investing.com South Africa", "published_at": "2026-06-24T19:09:47", "published_display": "24 Jun 2026 19:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Announces Hiring of Chief Scientific Officer", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/bionano-announces-hiring-chief-scientific-123000298.html", "source_name": "GlobeNewswire", "published_at": "2026-06-24T12:30:00+00:00", "published_display": "24 Jun 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano brings back OGM pioneer to lead science strategy July 20", "summary": "Bionano (NASDAQ: BNGO) has appointed Alex Hastie, Ph.D., as its Chief Scientific Officer, effective July 20, 2026. Dr. Hastie, a pivotal figure in Bionano's optical genome mapping (OGM) technology for 14 years, will now lead the company's global scientific strategy, innovation, a", "url": "https://www.stocktitan.net/news/BNGO/bionano-announces-hiring-of-chief-scientific-wpf8tya9iw5l.html", "source_name": "Stock Titan", "published_at": "2026-06-24T12:40:07", "published_display": "24 Jun 2026 12:40", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano appoints Alex Hastie as Chief Scientific Officer to lead global science strategy", "summary": "Bionano has appointed Alex Hastie, Ph.D. as Chief Scientific Officer, effective July 20, 2026. Hastie, who previously helped develop Bionano's optical genome mapping technology, will now lead the company's global scientific strategy, focusing on expanding clinical research applic", "url": "https://www.tradingview.com/news/tradingview:925f326ba94c6:0-bionano-appoints-alex-hastie-as-chief-scientific-officer-to-lead-global-science-strategy/", "source_name": "TradingView", "published_at": "2026-06-24T12:40:07", "published_display": "24 Jun 2026 12:40", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alex Hastie returns as Chief Scientific Officer at Bionano Genomics (NASDAQ: BNGO)", "summary": "Bionano Genomics, Inc. (NASDAQ: BNGO) announced the appointment of Alex Hastie, Ph.D., as its Chief Scientific Officer, effective July 20, 2026. Hastie, who previously spent 14 years at Bionano and was instrumental in developing its optical genome mapping (OGM) technologies, will", "url": "https://www.stocktitan.net/sec-filings/BNGO/8-k-bionano-genomics-inc-reports-material-event-1ed8c4e5b6ab.html", "source_name": "Stock Titan", "published_at": "2026-06-24T12:40:06", "published_display": "24 Jun 2026 12:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics (BNGO) Slips 1.72% as Stock Tests Key Support Levels - Factor Momentum", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxPSjB2XzJ0ejZjMFBUTEZHa3BMZzZ5VTk0N2pfamh1SkR6eTRYblp6U1hUTVAyaW9sVFRxc3V4bnJwelpiZ0h1bU9NeW5Ob3VmUGhPemJwWlhVNGo5QWhXRVNSem9Vemw3OHFEeC1nT1FRbkNZM2JMdi1aOWFXNG40ZVlnSnowbGtyQUw5bGVkQjlPdUN0X1dyY2R6TkJVMXpEaVRaOXh4SzFzak9oeHBFeXk0OHk?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-06-21T07:00:00+00:00", "published_display": "21 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Announces 67% Year-Over-Year Growth in Studies Featuring Optical Genome Mapping at ESHG 2026, Reflecting Expanding Global Adoption", "summary": "Bionano Genomics reported a 67% year-over-year increase in studies featuring optical genome mapping (OGM) at the 2026 European Society of Human Genetics (ESHG) conference, indicating growing global adoption. The 35 studies, up from 21 in 2025, originated from 17 countries across ", "url": "https://www.manilatimes.net/2026/06/18/tmt-newswire/globenewswire/bionano-announces-67-year-over-year-growth-in-studies-featuring-optical-genome-mapping-at-eshg-2026-reflecting-expanding-global-adoption/2368363/amp", "source_name": "The Manila Times", "published_at": "2026-06-18T20:16:00", "published_display": "18 Jun 2026 20:16", "sentiment": "positive", "sentiment_pct": 95, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano\u2019s genome-mapping studies jump to 35 at ESHG 2026", "summary": "Bionano (Nasdaq: BNGO) announced a 67% year-over-year increase in studies featuring its optical genome mapping (OGM) technology at ESHG 2026, reaching 35 studies from 17 countries. This growth highlights expanding global adoption across various research areas like rare genetic di", "url": "https://www.stocktitan.net/news/BNGO/bionano-announces-67-year-over-year-growth-in-studies-featuring-4tp1hdvm99bk.html", "source_name": "Stock Titan", "published_at": "2026-06-18T12:11:33", "published_display": "18 Jun 2026 12:11", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics Inc (BNGO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a detailed revenue breakdown for Bionano Genomics Inc (BNGO),", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bngo/revenue", "source_name": "TradingKey", "published_at": "2026-06-18T09:11:33", "published_display": "18 Jun 2026 09:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics reports 67% increase in studies at genetics conference", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxOUERuQ3RhRTNaM0owWGsxeW9wMEUzQ0p1dWRCUXNHN1I0dE1UTmZ3Y1BnbERrUGZ1ZDRBWGpkQnExNDVBRWF5amZmaDF0d0g1NTlKNHNmaURRYU5ZenotcHliTHdoTXN4QWRqQnF4b1Q3YTFybHlnRWRfd3dlZHRDSkY3Vl8zYzZYdDhIXzJMdVlXRTZvOEZpNXVJc2J2cjMtaUZDZXJUdHRGNjhpbG5wXzhTLTAtN1NuVThHQ0EzV1prT0pBbWc?oc=5", "source_name": "Investing.com", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics Inc (BNGO) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides details on the dividend and stock split history of Bionano Genomics Inc (BNGO). It notes that the company has not distributed any dividends in the past five years. However, it lists several stock merger events, including a 60-to-1 merger scheduled for Januar", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bngo/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-18T00:40:29", "published_display": "18 Jun 2026 00:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics Inc (BNGO) Risk Assessment: Volatility, Financial Risk & Investment Risk", "summary": "", "url": "https://news.google.com/rss/articles/CBMid0FVX3lxTE9kbUZELTBxUWw0V2gwRTdTOXhzSFFYQ1cxSlh2eWZlbEVCdjdNWHQwZkFSVi1ndEZsWDV6NEdrdWZCVURsbTdFTWFQa2hrcU1hQko5LTNVZElEdlJqem1VX1M0S1dzTlI5R0tmaGEtN0ZtRXlxWHJN?oc=5", "source_name": "TradingKey", "published_at": "2026-06-17T22:47:40+00:00", "published_display": "17 Jun 2026 22:47", "sentiment": "negative", "sentiment_pct": 5, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics Inc (BNGO) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "", "url": "https://news.google.com/rss/articles/CBMicEFVX3lxTE1FbDB5b0lqRkdSNC1TTE83WmlLMVh2NDR6YmRRRlNVRnctQThDS2pydmVMUkRxZ29BSnVHcXA2cUVDT1RuU1NGMzd4aS16SXFXZnNjdTY0cXFqRHFBdmc1dndkWWZIektjcV9oVmg0bDk?oc=5", "source_name": "TradingKey", "published_at": "2026-06-17T21:49:02+00:00", "published_display": "17 Jun 2026 21:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics Inc (BNGO) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "The article details the shareholder structure of Bionano Genomics Inc (BNGO), listing its major shareholders and institutional holdings. Key shareholders include Lincoln Alternative Strategies LLC and GSA Capital Partners LLP, with breakdowns by shareholder type such as hedge fun", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bngo/ownership", "source_name": "TradingKey", "published_at": "2026-06-17T22:40:29", "published_display": "17 Jun 2026 22:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics Inc (BNGO) Institutional Confidence", "summary": "Bionano Genomics Inc (BNGO) has an institutional shareholding score of 3.00, placing it 132nd out of 204 in the Healthcare Equipment & Supplies industry. The institutional shareholding proportion has increased by 354.71% quarter-over-quarter, reaching 10.52%. James Simons is the ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bngo/sentiment", "source_name": "TradingKey", "published_at": "2026-06-17T22:11:33", "published_display": "17 Jun 2026 22:11", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics Inc (BNGO) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "Bionano Genomics Inc (BNGO) has an earnings forecast score of 8.00 and an average price target of $7.50, with a high of $8.00 and a low of $7.00. Based on two analysts, the stock has a \"Buy\" rating with a target price upside of +334.78%. The company's expected revenue for the nex", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bngo/earnings", "source_name": "TradingKey", "published_at": "2026-06-17T18:40:29", "published_display": "17 Jun 2026 18:40", "sentiment": "positive", "sentiment_pct": 67, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Announces Multiple Publications in 2026 Describing Unique Utility of OGM in Studies of Reproductive Health and Prenatal Genetic Disorders", "summary": "Bionano Genomics announced 13 studies published in 2026, analyzing 730 samples, demonstrate the utility of optical genome mapping (OGM) for detecting structural variants in reproductive health and prenatal genetic disorders. These studies, conducted by independent research groups", "url": "https://www.manilatimes.net/2026/06/11/tmt-newswire/globenewswire/bionano-announces-multiple-publications-in-2026-describing-unique-utility-of-ogm-in-studies-of-reproductive-health-and-prenatal-genetic-disorders/2363593/amp", "source_name": "The Manila Times", "published_at": "2026-06-11T12:10:15", "published_display": "11 Jun 2026 12:10", "sentiment": "positive", "sentiment_pct": 93, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Infertility gene clues: 13 studies find hidden variants with Bionano mapping", "summary": "Bionano announced that 13 independent studies published in 2026 utilized optical genome mapping (OGM) to analyze 730 samples in reproductive health and prenatal genetics. These studies demonstrated OGM's effectiveness in identifying structural variants often missed by standard me", "url": "https://www.stocktitan.net/news/BNGO/bionano-announces-multiple-publications-in-2026-describing-unique-jxvucer5k4k1.html", "source_name": "Stock Titan", "published_at": "2026-06-11T12:10:15", "published_display": "11 Jun 2026 12:10", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans - moomoo", "summary": "This article details Bionano Genomics' S-8 filing, which is an initial registration statement concerning securities offered to employees through employee benefit plans. The filing was submitted to the SEC.", "url": "https://www.moomoo.com/news/notice/306737748/bionano-genomics-s-8-initial-registration-statement-for-securities-to", "source_name": "Moomoo", "published_at": "2026-06-09T07:39:07", "published_display": "09 Jun 2026 07:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics (BNGO) Upgraded to Buy: What Does It Mean for the Stock?", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxQbFl4VzE3WkVUY1ZzUnZFV0ZrdnlDVUdoaXZLZEhOb2V6UVdSVjVwRDZYYTRmdUJKb1Y0SW9OaW16dm13ZThteGJaWjJpUEJSMkZSSnBhRTgyOGstdHlwbFhvYUl2eDRQYWhJV2lBUW4xQ0ZxaU9xZl9Sa3JEU2d0dGY4a3JObnhGV0pQX3dkTWcxelFVa19YdWV6OFdZMlU4?oc=5", "source_name": "Market source", "published_at": "2026-06-08T07:00:00+00:00", "published_display": "08 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNano Genomics Announces Resignation of Chief Medical Officer", "summary": "BioNano Genomics announced the resignation of its Chief Medical Officer, Alka Chaubey, Ph.D., effective July 5, 2026. This departure may lead to adjustments in the company's clinical strategy. Analysts currently rate BNGO stock as a Buy with a $4.00 price target, though Spark, Ti", "url": "https://www.theglobeandmail.com/investing/markets/stocks/BNGO/pressreleases/2343224/bionano-genomics-announces-resignation-of-chief-medical-officer/", "source_name": "The Globe and Mail", "published_at": "2026-06-07T13:09:41", "published_display": "07 Jun 2026 13:09", "sentiment": "negative", "sentiment_pct": 38, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics (NASDAQ: BNGO) Chief Medical Officer to step down", "summary": "Bionano Genomics, Inc. announced that its Chief Medical Officer, Alka Chaubey, Ph.D., submitted her resignation on June 2, 2026, which will become effective on July 5, 2026. The company, traded on Nasdaq under BNGO, reported this material event in an 8-K filing. Albert A. Luderer", "url": "https://www.stocktitan.net/sec-filings/BNGO/8-k-bionano-genomics-inc-reports-material-event-d0d2275f7087.html", "source_name": "Stock Titan", "published_at": "2026-06-05T19:41:04", "published_display": "05 Jun 2026 19:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano appoints board chairman as interim CEO", "summary": "Bionano Genomics, Inc. (NASDAQ:BNGO) has appointed Al Luderer, its current board chairman, as interim president and CEO, effective Monday. Luderer, who has extensive biotechnology experience, will continue as chairman while Chris Twomey becomes Lead Independent Director. This lea", "url": "https://www.investing.com/news/company-news/bionano-appoints-board-chairman-as-interim-ceo-93CH-4665440", "source_name": "Investing.com", "published_at": "2026-06-05T11:09:15", "published_display": "05 Jun 2026 11:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics (BNGO) counsel has 24 shares withheld for RSU taxes", "summary": "Bionano Genomics' General Counsel, Jonathan V. Dixon, recently had 24 common shares withheld by the company to cover tax obligations related to a vested Restricted Stock Unit (RSU) award. This routine tax-withholding disposition, occurring on June 3, 2026, was priced at $1.30 per", "url": "https://www.stocktitan.net/sec-filings/BNGO/form-4-bionano-genomics-inc-insider-trading-activity-4d3b2e816d04.html", "source_name": "Stock Titan", "published_at": "2026-06-04T10:39:24", "published_display": "04 Jun 2026 10:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics (BNGO) COO records 27-share tax withholding event", "summary": "Bionano Genomics Chief Operating Officer Mark Oldakowski reported a tax-related disposition of 27 shares of common stock. These shares, valued at $1.30 each, were withheld by the company on June 3, 2026, to cover tax obligations arising from a vested restricted stock unit (RSU) a", "url": "https://www.stocktitan.net/sec-filings/BNGO/form-4-bionano-genomics-inc-insider-trading-activity-73e23c002fb6.html", "source_name": "Stock Titan", "published_at": "2026-06-04T01:10:06", "published_display": "04 Jun 2026 01:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics (BNGO) CMO has 24 vested shares withheld for tax obligations", "summary": "Bionano Genomics' Chief Medical Officer, Alka Chaubey, had 24 shares of common stock withheld by the company to cover tax obligations on vested restricted stock units (RSUs). The shares, valued at $1.30 each, were part of an RSU award granted on June 3, 2024, which vested on June", "url": "https://www.stocktitan.net/sec-filings/BNGO/form-4-bionano-genomics-inc-insider-trading-activity-5dbb823b71d7.html", "source_name": "Stock Titan", "published_at": "2026-06-04T01:10:06", "published_display": "04 Jun 2026 01:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics (BNGO) officer reports 7-share tax withholding", "summary": "Bionano Genomics' Principal Accounting Officer, Mark Adamchak, reported a routine tax-related share withholding of 7 common stock shares on June 3, 2026. The shares, valued at $1.30 each, were withheld by the company to cover tax obligations when an RSU award vested. Following th", "url": "https://www.stocktitan.net/sec-filings/BNGO/form-4-bionano-genomics-inc-insider-trading-activity-086054f5b100.html", "source_name": "Stock Titan", "published_at": "2026-06-04T01:10:06", "published_display": "04 Jun 2026 01:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Announces Full Retirement of Outstanding Senior Secured Convertible Debentures", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/bionano-announces-full-retirement-outstanding-120000380.html", "source_name": "GlobeNewswire", "published_at": "2026-05-28T12:00:00+00:00", "published_display": "28 May 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Fast-paced Mover Bionano Genomics (BNGO) Is a Great Choice for Value Investors", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPVUI5Y2pzeWMyRUpEOUFTWGFnYXQ0NnVBZG40bGs5SlJpelZ2TkR2U0Y5MzNsdkJHekRKMWhPbGpONVVjUkZUc1drZGpnZE12Slo0RTFSZWp6bnJobE1XZFhmVW9Za2xkaUpoemV1RGdBYUUyUkp3NDRmS1RCc2dhOUZ1WEpvU0xQR1NTZDBxUGZhUm94LUptUQ?oc=5", "source_name": "Market source", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Announces Largest OGM Study of T-Cell Acute Lymphoblastic Leukemia", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/bionano-announces-largest-ogm-study-120000855.html", "source_name": "GlobeNewswire", "published_at": "2026-05-26T12:00:00+00:00", "published_display": "26 May 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings call transcript: Bionano Genomics sees Q1 revenue growth, stock edges up", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxPd2RGWjJWUnhrX3lfMjF0cEdDSjhzNXVvbi1uR2RmMzVpY0t4RUdHbWFDYVF1SFQ5WVBPdHhtMzFBYkh4MlA4dk5zYzFwZGlrSFJKOTg5NWc5N3g3NllWc3AzVC1ZNG5xaVdIX2JaTVdCNFRmbnlSd193aHNHeXJCRXluaXBPb0hjUDZlOEpITGpYdFVlalJhd2tnd29RT1drX2FNYzVwRkJLLWdnNm1jQmRXQnI4MEppQll1WWJMejdZZTdyaTFENEVMb25nd0Zq?oc=5", "source_name": "Investing.com", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics, Inc. Q1 2026 Earnings Call Summary", "summary": "", "url": "https://finance.yahoo.com/m/e44ec90b-77b8-3bf3-a414-66e8e831afec/bionano-genomics%2C-inc.-q1.html", "source_name": "Moby", "published_at": "2026-05-14T12:30:00+00:00", "published_display": "14 May 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNano Genomics Names Interim CEO Amid Leadership Transition", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxPT0pwUGpJX1NTUzllNXpTOWUxVjU4TXdDcWlQNGpRV2c1LWF6blBhZ3lucEdsNF9yZlZVVlI1bFhTeTNNc1luN2hidW5nUVk5ZmxrQzRIMTF5S2VzeE9rZmQ4Qm1Kb1JqTU9KZ0xWeVVocHp5YmlOcnA2eUhOa1NzaThfZkN0MEw1bVdfRkY3R095UzUtam9sV215Y0VTMTBDcldXSFRsSE9STW5UOWVHZVFZTDNjVzBLd0Q0MW0xNHZPTjN2Y3NyQ2hBQTJZbnB5U01uZkRHUGw3MEpUVTJN?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics, Inc. Q4 2025 Earnings Call Summary", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNd19iWjBRZnZYMjNWbWJkV0VocXUxUjI2cVNMak16X3JmQTVNa1JKRk10TFFIMEI2N1pRZTd6UTk1NjZJek1YdUEzSTQzejRzMDVXUGgtdVpaQjRDMjFlMG5MZmxrY0VWWlZ0c3lkR0pKS3h0WjJVRXhWSTI4SFk0XzFlZG1wZ2tnOWpBMzRsbk5tVFBNTS1Eb21YSko2dw?oc=5", "source_name": "Market source", "published_at": "2026-03-23T07:00:00+00:00", "published_display": "23 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Market Cool On Bionano Genomics, Inc.'s (NASDAQ:BNGO) Revenues", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-30T08:00:00+00:00", "published_display": "30 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics Second Quarter 2025 Earnings: Beats Expectations", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-08-16T07:00:00+00:00", "published_display": "16 Aug 2025 07:00", "sentiment": "positive", "sentiment_pct": 85, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano to Report Second Quarter 2025 Financial Results and Host", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgJBVV95cUxPU3VfSmkxSDQyNzFtNDN4X2REYWpwWnlxdUFMTnhVMkpXUXBvZVV1SUNhR2JMTkhkU0swNTVLY19pTEt0MHNVaFF1dmJlQ0lmUlpRaG9ZemJQSERSa1pkdm5zLW9tbzZaX2djelpBZkhHaUN5T2FmS3RtUlJROWRoNERCUTJfSVZmWTd3YkN4bTZvUm5MRTdDYk1CVGw0TmF4M2ZHOWNBeEptNnpvNE1YRDZ4bnZrbHlNc3lfckxoNm5vVU1wZXJ6ME9XZ3IxX3JTcjBuVkdUemZKd1hvMkZmMEQzWUVudmFQNUVuT0ZPRWRWMnFrU0dORE1Ualk2Y1NRbnZzbWJn?oc=5", "source_name": "GuruFocus", "published_at": "2025-08-14T07:00:00+00:00", "published_display": "14 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics Retail Mood Turns \u2018Extremely Bearish\u2019 Amid Revenue Guidance Shortfall", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxPV29xcHlxaVBleEVnbFA4U19GSFNtcWtZcmZ2NkU2dG5ZZEx6cDIxUi1INjZzMVphOGpiLTRab1dmSURWV00xQkdkTXJqaS1XUzlpRG5zRlQ0bWNXSnE4QjRuTmh6Yl85Q1R2V2hJQ0VUWWN0RUU5OWljQl9CRDF2Sko0SlF0d1BVUnlhX3QtWEh0aXFPVmlnME9lZ0ZqQmpGNmJybEdsY09yU2dE?oc=5", "source_name": "Stocktwits", "published_at": "2025-05-15T03:12:29+00:00", "published_display": "15 May 2025 03:12", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics (BNGO) Stock Forecast and Price Target 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTFBDVTlVMTYwcTNPWU9sdVhLaWpibVExUlNOdjNpUC1VTlV4anZBNThYUko5Unk0bkxqSEVWQmJaUVlNMUhUdkxPaERObWxCMUR4VVN0SDNla2R2TU9LN0hIaDczdWRsdw?oc=5", "source_name": "MarketBeat", "published_at": "2024-05-11T13:08:05+00:00", "published_display": "11 May 2024 13:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What Is Going on With Bionano Genomics (BNGO) Stock Today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxQcVZELWtBeVl0eWxiejJwLVZDb0pmdEZFVmIySmZTZWpFZ0oybHBFYk9fdWd4Z3lsNnhndVp2eElZbmhxOV9YTUlxZWcwMnNuRmJaQXVKSldmWXRIWWpHd1pDcjNUSXdDVk16ZzZ5NXpDWDFkWTdjNWFrYVRGNlhCeURCSVZkVU5oRDZ2Tm1NVDkzMEY1?oc=5", "source_name": "InvestorPlace", "published_at": "2022-10-26T07:00:00+00:00", "published_display": "26 Oct 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics Stock: What Exactly Do They Do?", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTE1yVllMZk9MdkgzY2cyclVsMEVGM0ZFZHZyWjBNcFp0a1E1bEhGdTJzMXpqUTFndkRlQXJLNEZ4dHZKT3JxUTkxMEZMaTN6bHFFWkpkVHhTQzh6ZnYyYmxFQjBPS0xxdGpqZ05PdWczNDNXVDQxdUJjUQ?oc=5", "source_name": "Nanalyze", "published_at": "2022-04-13T07:00:00+00:00", "published_display": "13 Apr 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Is Not the Genomics Stock To Bet On", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxNME1LQ1UtTTZZczdvaGd6c3l5V2ZsVlNnY2tOZWYxZWNxVG1aOGNjTjdEVWozNUlYaDlhWS1YdDZjTXBLaEpLSWV5UDdEZmQtSi0wLTl2VHVhUGFQMWtxd0FZY0plRzBLcTVGVTI3M3JGSE96enRYSmhmWDEzb29iVUJ3?oc=5", "source_name": "Market source", "published_at": "2022-02-04T08:00:00+00:00", "published_display": "04 Feb 2022 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics Announces Closing of $230 Million", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2AJBVV95cUxPMlE5cnNkSjlDMkdsd0VjWE5pRXBiSDZVNFZKMzJOTXJDNXBGU2hwRGlwQU5Ybk5wMkpYSEdJMDI2azBHZ1NMV0hfaWx3ck94Sm04VDhwdHZoSURpRUoyWDlHOEI2WjNSc3d4anRhT0VJbndjdk45YWo0VjRwNWxPM2dDV0hwT1MtaWFWOVAtYVZSMC1nOGdCdlk4ekE2NmNSdmg0ZDVkWjNFdDk0cjJqc1g0dWUycHJxTUVoc3I1dElfVWliU1hoNXJqblpZMnUxRzdFOUppTC1jQ1lsbkRic0JFRzlodjc1Rk9kVldRU1VjU0pqUlVpNW1HV1h2TzJuejRTU1VlZkZSRGN3WVlVTHZZbXhBWktlMG56LU5VWFBPd1d4cl8wV0FKR1pQYTM2Uktuc19sTVFjX1FxMUc0b2lJcUpfWFVvdFpMVWplSFJnRlJaam5wUg?oc=5", "source_name": "GlobeNewswire", "published_at": "2021-01-25T08:00:00+00:00", "published_display": "25 Jan 2021 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics, Inc.: Target Price Consensus and Analysts Recommendations | BNGO | US09075F4046", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxPNl9QdDNfZlpYN29kVWxzUEZJUmRYekw0dlgxY0w5aFhjeDhGXzBuUFJCN3ptSUZUYXRoQ2JXMjlkV3ItVDBMUzVPOUNMcGhZNlJQTTBYYm5xUTdQVGpfUTdUWXpXMk5rb29NYkhlbklEVUtxOUtpZFB4Snl2NkozNjl0WnBVSlYzZW9R?oc=5", "source_name": "marketscreener.com", "published_at": "2020-08-31T22:03:04+00:00", "published_display": "31 Aug 2020 22:03", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics (BNGO) Stock News & Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTkFVX3lxTFBpVGxJREtuLXBYMEU2Mmd4Q1k4WEZZOGVFNDkxNGNPYWNnandmTGdvaWxrT1M5aEgwMV9nU2gwTE9nb0tMSnc4NVZiWDlHdw?oc=5", "source_name": "Stock Titan", "published_at": "2020-08-20T13:40:34+00:00", "published_display": "20 Aug 2020 13:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BNGO: Bionano Genomics - Full Company Report", "summary": "", "url": "https://news.google.com/rss/articles/CBMiaEFVX3lxTE9FT1RScGc5WjhBOTZZUF9wYm53aW5vMHFJYTNmbzRES3dmV0I0ZkJOOHdNZUNkY0EtbExqb1o1YTFjWFhCbjE5b2VMU2pNLUkxSWt3ZUFVZHlRdHhRVXBaVkQxZDJhc05r?oc=5", "source_name": "Zacks Investment Research", "published_at": "2018-09-26T10:50:58+00:00", "published_display": "26 Sep 2018 10:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionano Genomics (BNGO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiT0FVX3lxTE9wSTlrV2JsVUhYRTJFd1N4YmxvNTAzV2U2REtpUTltMDZQYkN1dWJJZXltZ3JtdEYzVUJVLTFNRnRCU2tJWE16dHJmbXdHbjA?oc=5", "source_name": "Zacks Investment Research", "published_at": "2018-09-26T10:05:51+00:00", "published_display": "26 Sep 2018 10:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The maize W22 genome provides a foundation for functional genomics and transposon biology", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXkFVX3lxTE53LWNwX2psc3VpZjZFZHBCT2ZpNllhSjd6Njk2RWhuU1dkbjZwOExnc1FtZE5lcUptX3BxLVA1RndNQTkwVFJHM0VfbG1kc3BORDBCVkFIVnVWNjNkNHc?oc=5", "source_name": "Nature", "published_at": "2018-07-30T07:00:00+00:00", "published_display": "30 Jul 2018 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BNGO: Bionano Genomics Inc Latest Stock Price, Analysis, News and Trading Ideas", "summary": "", "url": "https://news.google.com/rss/articles/CBMiSkFVX3lxTE1adTQ4QzVJZnJVOFd2VWFRd0dGQnBSX2RIODI1QnltRlY5NS1xY1pDR0k2cU9iNUM5OGtCWjloTGEyX2pDUWQ0WjJn?oc=5", "source_name": "Stocktwits", "published_at": "2018-07-03T21:51:16+00:00", "published_display": "03 Jul 2018 21:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 94, "total_relevant": 59, "sentiment_summary": {"positive": 14, "negative": 6, "neutral": 39, "score": 55, "total": 59, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 86, "events": [{"event": "general", "label": "Market update", "weight": 24.35, "count": 43}, {"event": "earnings", "label": "Earnings", "weight": 5.5, "count": 10}, {"event": "analyst", "label": "Analyst action", "weight": 2.2, "count": 4}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 14, "negative_events": 6}, "market_context": {"has_market_context": true, "latest_close": 1.2, "latest_week": "2026-07-10", "one_week_move": 4.3, "four_week_move": 3.4, "twelve_week_move": -7.0, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 1.374253, "market_dynamics_buy_signal": false, "relative_strength": -43.177095, "fair_value_gap": -97.1, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 35.6358, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+4.3% over one week, +3.4% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 66, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 10}, {"label": "TradingKey", "count": 7}, {"label": "TradingView", "count": 5}, {"label": "GlobeNewswire", "count": 4}, {"label": "Market source", "count": 4}, {"label": "The Globe and Mail", "count": 3}, {"label": "Investing.com", "count": 3}, {"label": "The Manila Times", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 59}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 43}, {"label": "Earnings", "count": 10}, {"label": "Analyst action", "count": 4}, {"label": "Deals and strategy", "count": 1}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "55/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "86/100 classification confidence."}, {"label": "Company focus", "value": "59", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "2", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+4.3% over one week, +3.4% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Negative", "tone": "negative", "text": "Precision Trading with Bionano Genomics Inc. (BNGO) Risk Zones"}], "updated_at": "2026-07-16T04:33:39.889987+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}